Citation 35388

LETTERON,P: LABBE,G: DEGOTT,D: BERSON,A: FROMENTY,B: DELAFORGE,M: LARREY,D: PESSAYRE,D:. (1990). MECHANISM FOR THE PROTECTIVE EFFECTS OF SILYMARIN AGAINST CARBON TETRACHLORIDE-INDUCED LIPID PEROXIDATION AND HEPATOTOXICITY IN MICE. EVIDENCE THAT SILYMARIN ACTS BOTH AS AN INHIBITOR OF METABOLIC ACTIVATION AND AS A CHAIN-BREAKING ANTIOXIDANT.. 39(12)

Citation Details

Title	MECHANISM FOR THE PROTECTIVE EFFECTS OF SILYMARIN AGAINST CARBON TETRACHLORIDE-INDUCED LIPID PEROXIDATION AND HEPATOTOXICITY IN MICE. EVIDENCE THAT SILYMARIN ACTS BOTH AS AN INHIBITOR OF METABOLIC ACTIVATION AND AS A CHAIN-BREAKING ANTIOXIDANT.
Authors	LETTERON,P: LABBE,G: DEGOTT,D: BERSON,A: FROMENTY,B: DELAFORGE,M: LARREY,D: PESSAYRE,D:
Year	1990
Volume	39
Issue	12

Summary

Year: 1990

Journal: Unknown

Organisms and Their Experiments (3)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VIVO	SILYMARIN	ACTIVE
2	LIPID PEROXIDE FORMATION INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VIVO	SILYMARIN	ACTIVE
3	MONOOXYGENASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITRO	SILYMARIN	ACTIVE
4	LIPID PEROXIDE FORMATION INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITRO	SILYMARIN	ACTIVE
5	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	SILYMARIN	INACTIVE
6	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	SILYMARIN	ACTIVE
7	MONOOXYGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SILYMARIN	ACTIVE
8	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SILYMARIN	INACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VIVO	SILYDIANIN	ACTIVE
2	LIPID PEROXIDE FORMATION INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VIVO	SILYDIANIN	ACTIVE
3	MONOOXYGENASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITRO	SILYDIANIN	ACTIVE
4	LIPID PEROXIDE FORMATION INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITRO	SILYDIANIN	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	SILYCHRISTIN	ACTIVE
2	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	SILYCHRISTIN	ACTIVE
3	MONOOXYGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SILYCHRISTIN	ACTIVE
4	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SILYCHRISTIN	ACTIVE

Citation 35388

Citation Details

Summary

Organisms and Their Experiments (3)

Unknown organism

Unknown organism

Unknown organism

Show SPARQL Queries (1)

Query 1